TrialBMC pediatrics2019

Infliximab for pediatric patients with ulcerative colitis: a phase 3, open-label, uncontrolled, multicenter trial in Japan.

Hitoshi Tajiri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.